Neurobiology of Disease,
Год журнала:
2025,
Номер
unknown, С. 106888 - 106888
Опубликована: Апрель 1, 2025
Epilepsy
is
a
severe
common
neurological
disease
affecting
all
ages.
with
onset
before
the
age
of
5
years,
designated
early-onset
epilepsy
(EOE),
special
importance.
According
to
previous
studies,
genetic
factors
contribute
significantly
pathogenesis
EOE
that
remains
unclear
and
must
be
explored.
So,
list
229
well-selected
EOE-associated
genes
expressed
in
brain
was
created
for
investigation
molecular
mechanisms
involved
its
pathogenesis.
Enrichment
analysis
showed
among
significant
pathways
were
nicotine
addiction,
GABAergic
synapse,
synaptic
vesicle
cycle,
regulation
membrane
potential,
cholinergic
dopaminergic
morphine
addiction.
Performing
an
integrated
as
well
protein-protein
interaction
network-based
approaches
use
GO,
KEGG,
ClueGO,
cytoHubba
3
network
metrics,
12
hub
identified,
seven
which,
CDKL5,
GABRA1,
KCNQ2,
KCNQ3,
SCN1A,
SCN8A
STXBP1,
identified
key
(via
Venn
diagram
analysis).
These
are
mostly
enriched
SNARE
interactions
vesicular
transport,
potential
exocytosis.
Clustering
PPI
via
MCODE
functional
modules,
indicating
also
other
such
N-Glycan
biosynthesis
protein
N-linked
glycosylation,
retrograde
endocannabinoid
signaling,
mTOR
signaling
aminoacyl-tRNA
biosynthesis.
Drug-gene
number
drugs
medications
EOE,
which
non-FDA
approved
azetukalner
(under
clinical
development),
indiplon
ICA-105665
FDA
retigabine,
ganaxolone
methohexital.
Translational Psychiatry,
Год журнала:
2023,
Номер
13(1)
Опубликована: Май 8, 2023
Abstract
Glycosylation,
the
addition
of
glycans
or
carbohydrates
to
proteins,
lipids,
other
glycans,
is
a
complex
post-translational
modification
that
plays
crucial
role
in
cellular
function.
It
estimated
at
least
half
all
mammalian
proteins
undergo
glycosylation,
underscoring
its
importance
functioning
cells.
This
reflected
fact
significant
portion
human
genome,
around
2%,
devoted
encoding
enzymes
involved
glycosylation.
Changes
glycosylation
have
been
linked
various
neurological
disorders,
including
Alzheimer’s
disease,
Parkinson’s
autism
spectrum
disorder,
and
schizophrenia.
Despite
widespread
occurrence,
central
nervous
system
remains
largely
unknown,
particularly
with
regard
impact
on
behavioral
abnormalities
brain
diseases.
review
focuses
examining
three
types
glycosylation:
N-glycosylation,
O-glycosylation,
O-GlcNAcylation,
manifestation
symptoms
neurodevelopmental,
neurodegenerative,
neuropsychiatric
disorders.
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Янв. 4, 2024
Abstract
N-
glycosylation
is
an
abundant
post-translational
modification
of
most
cell-surface
proteins.
glycans
play
a
crucial
role
in
cellular
functions
like
protein
folding,
localization,
cell–cell
signaling,
and
immune
detection.
As
different
tissue
types
display
glycan
profiles,
changes
compositions
occur
tissue-specific
ways
with
development
disease,
cancer.
However,
no
comparative
atlas
resource
exists
for
documenting
glycome
alterations
across
various
human
types,
particularly
comparing
normal
cancerous
tissues.
In
order
to
study
broad
range
N
-glycomes,
-glycan
targeted
MALDI
imaging
mass
spectrometry
was
applied
custom
formalin-fixed
paraffin-embedded
microarrays.
These
encompassed
fifteen
including
bladder,
breast,
cervix,
colon,
esophagus,
gastric,
kidney,
liver,
lung,
pancreas,
prostate,
sarcoma,
skin,
thyroid,
uterus.
Each
array
contained
both
tumor
cores
from
the
same
pathology
block,
selected
by
pathologist,
allowing
more
in-depth
comparisons
differences
between
types.
Using
established
MALDI-IMS
workflows
existing
databases,
present
each
core
were
spatially
profiled
peak
intensity
data
compiled
analyses.
Further
structural
information
determined
fucosylation
using
endoglycosidase
F3,
differentiation
sialic
acid
linkages
through
stabilization
chemistry.
Glycan
compared
oligomannose
levels,
branching
complexity,
presence
bisecting
acetylglucosamine,
fucosylation,
sialylation.
Collectively,
our
research
identified
that
significantly
increased
and/or
decreased
relative
abundance
cancer
type.
This
offers
valuable
on
wide
scale
tissues,
serving
as
reference
future
studies
potential
diagnostic
applications
MALDI-IMS.
Molecular Genetics and Metabolism,
Год журнала:
2024,
Номер
142(1), С. 108476 - 108476
Опубликована: Апрель 10, 2024
We
have
identified
200
congenital
disorders
of
glycosylation
(CDG)
caused
by
189
different
gene
defects
and
proposed
a
classification
system
for
CDG
based
on
the
mode
action.
This
includes
8
categories:
1.
Disorders
monosaccharide
synthesis
interconversion,
2.
nucleotide
sugar
transport,
3.
N-linked
protein
glycosylation,
4.
O-linked
5.
lipid
6.
vesicular
trafficking,
7.
multiple
pathways
8.
glycoprotein/glycan
degradation.
Additionally,
using
information
from
IEMbase,
we
described
clinical
involvement
19
organs
systems,
as
well
essential
laboratory
investigations
each
type
CDG.
Neurological,
dysmorphic,
skeletal,
ocular
manifestations
were
most
prevalent,
occurring
in
81%,
56%,
53%,
46%
CDG,
respectively.
was
followed
digestive,
cardiovascular,
dermatological,
endocrine,
hematological
symptoms
(17-34%).
Immunological,
genitourinary,
respiratory,
psychiatric,
renal
less
frequently
reported
(8-12%),
with
hair
dental
abnormalities
present
only
4-7%
The
provided
this
study,
including
our
may
be
beneficial
healthcare
providers
caring
individuals
metabolic
conditions
associated
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Май 13, 2023
Abstract
Matrix
assisted
laser
desorption/ionization
imaging
has
greatly
improved
our
understanding
of
spatial
biology,
however
a
robust
bioinformatic
pipeline
for
data
analysis
is
lacking.
Here,
we
demonstrate
the
application
high-dimensionality
reduction/spatial
clustering
and
histopathological
annotation
matrix
datasets
to
assess
tissue
metabolic
heterogeneity
in
human
lung
diseases.
Using
features
identified
from
this
pipeline,
hypothesize
that
channeling
between
glycogen
N-linked
glycans
critical
process
favoring
pulmonary
fibrosis
progression.
To
test
hypothesis,
induced
two
different
mouse
models
with
lysosomal
utilization
deficiency.
Both
displayed
blunted
glycan
levels
nearly
90%
reduction
endpoint
when
compared
WT
animals.
Collectively,
provide
conclusive
evidence
required
In
summary,
study
provides
roadmap
leverage
metabolomics
understand
foundational
biology
Biomolecules,
Год журнала:
2024,
Номер
14(3), С. 282 - 282
Опубликована: Фев. 27, 2024
Glycosylation,
a
prevalent
post-translational
modification,
plays
pivotal
role
in
regulating
intricate
cellular
processes
by
covalently
attaching
glycans
to
macromolecules.
Dysregulated
glycosylation
is
linked
spectrum
of
diseases,
encompassing
cancer,
neurodegenerative
disorders,
congenital
infections,
and
inflammation.
This
review
delves
into
the
interplay
between
protein
conformation,
with
specific
focus
on
profound
impact
N-glycans
selection
distinct
conformations
characterized
interactomes—namely,
assemblies—under
normal
pathological
conditions
across
various
diseases.
We
begin
examining
spike
SARS
virus,
illustrating
how
regulate
infectivity
pathogenic
agents.
Subsequently,
we
utilize
prion
chaperone
glucose-regulated
94
as
examples,
exploring
instances
where
N-glycosylation
transforms
physiological
structures
disease-associated
forms.
Unraveling
these
connections
provides
valuable
insights
potential
therapeutic
avenues
deeper
comprehension
molecular
intricacies
that
underlie
disease
conditions.
exploration
glycosylation’s
influence
conformation
effectively
bridges
gap
glycome
disease,
offering
comprehensive
perspective
implications
targeting
conformational
mutants
their
pathologic
assemblies
The
goal
unravel
nuances
modifications,
shedding
light
they
contribute
assembly,
disease.
Alzheimer s & Dementia,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 25, 2024
Abstract
BACKGROUND
Synaptic
and
extrasynaptic
distribution
of
N‐methyl‐D‐aspartate
receptors
(NMDARs)
has
not
been
addressed
in
the
brain
from
Alzheimer´s
disease
(AD)
subjects,
despite
their
contribution
to
neurodegeneration.
METHODS
We
have
developed
a
protocol
isolate
synaptic
membranes
controls
AD
frontal
cortex.
characterized
NMDAR
subunits
GluN2B,
GluN2A,
GluN1,
GluN3A,
as
well
post‐translational
modifications,
such
phosphorylation
glycosylation.
RESULTS
Lower
levels
GluN2B
GluN2A
were
found
fractions,
while
GluN1
significantly
higher;
GluN3A
remained
unaffected
AD.
also
identified
different
glycoforms
membranes.
Tyr1472
was
lower
fractions.
DISCUSSION
Reduction
subunits,
particularly
for
is
likely
contribute
transmission
failure
Additionally,
increment
could
favor
activation
excitotoxicity
Highlights
New
human
Low
High
Specific
GluN2A.
at
Journal of Extracellular Vesicles,
Год журнала:
2023,
Номер
13(1)
Опубликована: Дек. 29, 2023
Cerebrospinal
fluid
(CSF)
is
a
clear,
transparent
derived
from
blood
plasma
that
protects
the
brain
and
spinal
cord
against
mechanical
shock,
provides
buoyancy,
clears
metabolic
waste
transports
extracellular
components
to
remote
sites
in
brain.
Given
its
contact
with
cord,
CSF
most
informative
biofluid
for
studies
of
central
nervous
system
(CNS).
In
addition
other
components,
contains
vesicles
(EVs)
carry
bioactive
cargoes
(e.g.,
lipids,
nucleic
acids,
proteins),
can
have
biological
functions
within
beyond
CNS.
Thus,
EVs
likely
serve
as
both
mediators
contributors
communication
Accordingly,
their
potential
biomarkers
CNS
diseases
has
stimulated
much
excitement
attention
EV
research.
However,
on
present
unique
challenges
relative
biofluids,
including
invasive
nature
collection,
limited
volumes
low
numbers
compared
plasma.
Here,
objectives
International
Society
Extracellular
Vesicles
Task
Force
are
promote
reproducibility
by
providing
current
reporting
best
practices,
recommendations
guidelines,
studies.
To
accomplish
this,
we
created
distributed
world-wide
survey
ISEV
members
assess
methods
considered
'best
practices'
EVs,
then
performed
detailed
literature
review
publications
was
used
curate
resources.
Based
responses
curated
information
publications,
herein
guidelines
seven
domains:
(i)
Collection,
Processing,
Storage;
(ii)
Separation/Concentration;
(iii)
Size
Number
Measurements;
(iv)
Protein
Studies;
(v)
RNA
(vi)
Omics
Studies
(vii)
Functional
Studies.
Ageing Research Reviews,
Год журнала:
2023,
Номер
89, С. 101991 - 101991
Опубликована: Июнь 21, 2023
Glycosylation
is
a
common
post-translational
modification
of
brain
proteins
including
cell
surface
adhesion
molecules,
synaptic
proteins,
receptors
and
channels,
as
well
intracellular
with
implications
in
development
functions.
Using
advanced
state-of-the-art
glycomics
glycoproteomics
technologies
conjunction
glycoinformatics
resources,
characteristic
glycosylation
profiles
tissues
are
increasingly
reported
the
literature
growing
evidence
shows
deregulation
central
nervous
system
disorders,
aging
associated
neurodegenerative
diseases.
Glycan
signatures
tissue
also
frequently
described
cerebrospinal
fluid
due
to
its
enrichment
brain-derived
molecules.
A
detailed
structural
analysis
glycans
collected
publications
healthy
conditions
was
undertaken
data
compiled
create
browsable
dedicated
set
GlyConnect
database
glycoproteins
(https://glyconnect.expasy.org/brain).
The
shared
molecular
composition
enhances
likelihood
novel
glycobiomarker
discovery
for
neurodegeneration,
which
may
aid
unveiling
disease
mechanisms,
therefore,
providing
therapeutic
targets
diagnostic
progression
monitoring
tools.
Journal of Neurochemistry,
Год журнала:
2023,
Номер
168(5), С. 728 - 743
Опубликована: Авг. 9, 2023
Abstract
Glycogen
is
a
biologically
essential
macromolecule
that
directly
involved
in
multiple
human
diseases.
While
its
primary
role
carbohydrate
storage
and
energy
metabolism
the
liver
muscle
well
characterized,
recent
research
has
highlighted
critical
metabolic
non‐metabolic
roles
for
glycogen
brain.
In
this
review,
emerging
of
homeostasis
healthy
diseased
brain
are
discussed
with
focus
on
advancing
our
understanding
Innovative
technologies
have
led
to
novel
insights
into
functions
detailed.
Key
how
cellular
localization
impacts
neuronal
glial
function
discussed.
Perturbed
observed
disorders
brain,
including
where
it
serves
as
disease
driver
category
neurological
diseases
(n‐GSDs).
n‐GSDs
include
Lafora
(LD),
adult
polyglucosan
body
(APBD),
Cori
disease,
Glucose
transporter
type
1
deficiency
syndrome
(G1D),
GSD0b,
late‐onset
Pompe
(PD).
They
neurogenetic
characterized
by
aberrant
which
results
devastating
systemic
symptoms.
most
severe
cases,
rapid
neurodegeneration
coupled
dementia
death
soon
after
diagnosis.
Finally,
we
discuss
current
treatment
strategies
currently
being
developed
potential
be
great
benefit
patients
n‐GSD.
Taken
together,
biological
resulted
renaissance
dramatically
advanced
both
biology
disease.
Future
studies
needed
expand
multifaceted
effectively
apply
these
image